Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:CIK NYSE:ECC NYSE:HQL NYSE:TWN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCIKCredit Suisse Asset Management Income Fund$2.53-0.4%$2.55$2.44▼$3.04$138.80M0.57473,523 shs867,781 shsECCEagle Point Credit$4.04-0.1%$3.92$3.46▼$7.99$533.47M0.351.93 million shs702,302 shsHQLabrdn Life Sciences Investors$17.18-0.2%$17.22$12.12▼$18.46$522.57M0.77118,782 shs111,362 shsTWNTaiwan Fund$93.74+3.9%$77.88$36.54▼$99.77$542.73M1.4234,127 shs128,539 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCIKCredit Suisse Asset Management Income Fund0.00%+0.40%-1.17%-7.64%-9.29%ECCEagle Point Credit-0.74%-0.74%+1.00%-0.25%-46.39%HQLabrdn Life Sciences Investors-2.55%-5.60%-3.67%+2.59%+36.70%TWNTaiwan Fund+1.70%-5.03%+9.26%+46.82%+146.70%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCIKCredit Suisse Asset Management Income Fund$2.53-0.4%$2.55$2.44▼$3.04$138.80M0.57473,523 shs867,781 shsECCEagle Point Credit$4.04-0.1%$3.92$3.46▼$7.99$533.47M0.351.93 million shs702,302 shsHQLabrdn Life Sciences Investors$17.18-0.2%$17.22$12.12▼$18.46$522.57M0.77118,782 shs111,362 shsTWNTaiwan Fund$93.74+3.9%$77.88$36.54▼$99.77$542.73M1.4234,127 shs128,539 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCIKCredit Suisse Asset Management Income Fund0.00%+0.40%-1.17%-7.64%-9.29%ECCEagle Point Credit-0.74%-0.74%+1.00%-0.25%-46.39%HQLabrdn Life Sciences Investors-2.55%-5.60%-3.67%+2.59%+36.70%TWNTaiwan Fund+1.70%-5.03%+9.26%+46.82%+146.70%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCIKCredit Suisse Asset Management Income Fund 0.00N/AN/AN/AECCEagle Point Credit 2.50Moderate Buy$6.6765.22% UpsideHQLabrdn Life Sciences Investors 0.00N/AN/AN/ATWNTaiwan Fund 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CIK, HQL, TWN, and ECC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/1/2026ECCEagle Point Credit Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold4/15/2026ECCEagle Point Credit Alliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy3/16/2026ECCEagle Point Credit B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$7.00 ➝ $4.253/10/2026ECCEagle Point Credit Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell3/2/2026ECCEagle Point Credit LADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Neutral(Data available from 5/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCIKCredit Suisse Asset Management Income FundN/AN/AN/AN/AN/AN/AECCEagle Point Credit$203.99M2.62N/AN/A$5.94 per share0.68HQLabrdn Life Sciences InvestorsN/AN/AN/AN/AN/AN/ATWNTaiwan FundN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCIKCredit Suisse Asset Management Income FundN/AN/AN/AN/AN/AN/AN/AN/AN/AECCEagle Point Credit-$115M$0.1921.245.31N/A12.33%13.47%8.14%N/AHQLabrdn Life Sciences InvestorsN/AN/AN/AN/AN/AN/AN/AN/AN/ATWNTaiwan FundN/AN/AN/AN/AN/AN/AN/AN/AN/ALatest CIK, HQL, TWN, and ECC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2026Q1 2026ECCEagle Point Credit$0.2267$0.20-$0.0267-$1.12$48.79 million$42.40 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCIKCredit Suisse Asset Management Income Fund$0.2610.28%N/AN/AN/AECCEagle Point Credit$1.5237.67%+6.26%800.00%N/AHQLabrdn Life Sciences Investors$1.9111.11%N/AN/AN/ATWNTaiwan Fund$6.206.61%N/AN/AN/ALatest CIK, HQL, TWN, and ECC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/12/2026ECCEagle Point Creditmonthly$0.0617.63%9/10/20269/10/20269/30/20265/12/2026ECCEagle Point Creditmonthly$0.0617.63%8/11/20268/11/20268/31/20265/12/2026ECCEagle Point Creditmonthly$0.0617.63%7/13/20267/13/20267/31/20265/11/2026HQLabrdn Life Sciences Investorsquarterly$0.5613.02%5/21/20265/21/20266/30/20265/11/2026HQLabrdn Life Sciences Investorsquarterly$0.5612.35%5/21/20265/21/20265/30/20265/1/2026CIKCredit Suisse Asset Management Income Fundmonthly$0.029.6%5/15/20265/15/20265/22/20264/1/2026CIKCredit Suisse Asset Management Income Fundmonthly$0.029.3%4/16/20264/16/20264/23/20263/2/2026CIKCredit Suisse Asset Management Income Fundmonthly$0.029.38%3/16/20263/16/20263/23/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCIKCredit Suisse Asset Management Income FundN/AN/AN/AECCEagle Point CreditN/A0.330.33HQLabrdn Life Sciences InvestorsN/AN/AN/ATWNTaiwan FundN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCIKCredit Suisse Asset Management Income Fund29.49%ECCEagle Point Credit19.50%HQLabrdn Life Sciences Investors32.21%TWNTaiwan FundN/AInsider OwnershipCompanyInsider OwnershipCIKCredit Suisse Asset Management Income Fund18.63%ECCEagle Point Credit0.26%HQLabrdn Life Sciences Investors10.06%TWNTaiwan Fund2.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCIKCredit Suisse Asset Management Income Fund654.86 million44.64 millionNot OptionableECCEagle Point CreditN/A132.21 million131.87 millionNot OptionableHQLabrdn Life Sciences InvestorsN/A30.41 million27.35 millionNot OptionableTWNTaiwan FundN/A5.79 million5.68 millionNot OptionableCIK, HQL, TWN, and ECC HeadlinesRecent News About These CompaniesTaiwan Fund (NYSE:TWN) Sets New 12-Month High - Time to Buy?May 6, 2026 | marketbeat.comTaiwan Fund (NYSE:TWN) Reaches New 12-Month High - What's Next?April 30, 2026 | marketbeat.comTaiwan Fund (NYSE:TWN) Hits New 12-Month High - Should You Buy?April 22, 2026 | marketbeat.comWilliam Kirby Acquires 50,687 Shares of Taiwan Fund (NYSE:TWN) StockFebruary 28, 2026 | insidertrades.comTWN: Prepare For Profit TakingFebruary 12, 2026 | seekingalpha.comThe Taiwan Fund, Inc. Announces 1st Quarter EarningsJanuary 14, 2026 | prnewswire.comThe Taiwan Fund, Inc. Declares DistributionsDecember 15, 2025 | prnewswire.comTaiwan Rolls Out $40B Defense Supplemental to Fund Air Defense, Asymmetric CapabilitiesNovember 27, 2025 | news.usni.orgNTaiwan Creative Content Fest Opens With Fund Launches, Cross-Border Collaboration & Praise For Local Hit ‘96 Minutes'November 4, 2025 | msn.comCJ ENM and Far EasTone Lead Launch of Twin Content Funds at Taiwan Creative Content FestNovember 4, 2025 | msn.comCJ ENM Hong Kong Partners With Taiwan’s Far EasTone Telecom & TVBS On $30M Fund To Invest In Mandarin-language ContentNovember 4, 2025 | msn.comThe Taiwan Fund, Inc. Announces a New Conditional Tender Offer PolicyOctober 20, 2025 | prnewswire.comThe Taiwan Fund, Inc. Announces a New Conditional Tender Offer PolicyOctober 20, 2025 | prnewswire.comTaiwan's Defence Ministry To Seek Up To $33 Bn In Special Funding: Lawmaker To AFPSeptember 12, 2025 | barrons.comMore Investors To Join Taiwan's US$3.4B Green Growth FundJuly 18, 2025 | msn.comThe Taiwan Fund, Inc. Announces 3rd Quarter EarningsJuly 16, 2025 | prnewswire.comTaiwan Dollar Hits Three-Year High on Fund Inflows, RepatriationJune 26, 2025 | bloomberg.comTWN: Worth A Relook After Taiwan's Tech SelloffMay 24, 2025 | seekingalpha.comTaiwan to set up sovereign wealth fundMay 20, 2025 | msn.comTaiwan president announces sovereign wealth fund, highlights 'friction' in U.S. trade negotiationsMay 20, 2025 | pionline.comPTaiwan Plans Wealth Fund to Counter China With Global ExpansionMay 20, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCIK, HQL, TWN, and ECC Company DescriptionsCredit Suisse Asset Management Income Fund NYSEAMERICAN:CIK$2.53 -0.01 (-0.39%) Closing price 04:10 PM EasternExtended Trading$2.52 0.00 (-0.20%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Credit Suisse Asset Management Income Fund, Inc. is a closed-ended fixed income mutual fund launched and managed by Credit Suisse Asset Management, LLC. The fund invests in the fixed income markets of the United States. It primarily invests in high yield corporate debt such as bonds and debentures that are rated Baa or lower by Moody's or BBB or lower by S&P. The fund benchmarks the performance of its portfolio against the BofA Merrill Lynch US High Yield Master II Constrained Index. Credit Suisse Asset Management Income Fund, Inc. was formed on February 11, 1987 and is domiciled in the United States.Eagle Point Credit NYSE:ECC$4.04 -0.01 (-0.12%) Closing price 03:58 PM EasternExtended Trading$4.03 0.00 (-0.02%) As of 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Eagle Point Credit Company Inc. is a closed ended fund launched and managed by Eagle Point Credit Management LLC. It invests in fixed income markets of the United States. The fund invests equity and junior debt tranches of collateralized loan obligations consisting primarily of below investment grade U.S. senior secured loans. Eagle Point Credit Company Inc. was formed on March 24, 2014 and is domiciled in the United States.abrdn Life Sciences Investors NYSE:HQL$17.18 -0.03 (-0.15%) Closing price 03:59 PM EasternExtended Trading$17.18 +0.00 (+0.01%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.Taiwan Fund NYSE:TWN$93.74 +3.50 (+3.87%) Closing price 03:59 PM EasternExtended Trading$93.76 +0.02 (+0.03%) As of 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.The Taiwan Fund, Inc. is a closed-ended equity mutual fund launched and managed by Nomura Asset Management U.S.A. Inc. It invests in the public equity markets of Taiwan. The fund seeks to invest in stocks of companies operating across diversified sectors. It employs fundamental analysis focusing on such factors as overall growth prospects, competitive position in the respective industry, technology, research, and development, productivity, labor costs, raw material costs and sources, profit margins, return on investment, capital resources, government regulation, and management to create its portfolio. The fund benchmarks the performance of its portfolio against the TAIEX Total Return Index. The Taiwan Fund, Inc. was formed on December 23, 1986 and is domiciled in the United States. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Intuit's Great SaaS Reset: Fired By AI Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish Target Shows Strengths, But Analysts Want to See More Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
